{"id":"concomitant-therapy-10-days","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to penicillin-binding proteins, which are essential for bacterial cell wall formation. This leads to the disruption of the bacterial cell wall, ultimately causing the death of the bacteria. The drug is effective against a wide range of Gram-positive and Gram-negative bacteria.","oneSentence":"This drug is used to treat various infections by inhibiting the bacterial cell wall synthesis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:30:48.378Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Skin and soft tissue infections"}]},"trialDetails":[{"nctId":"NCT03412877","phase":"PHASE2","title":"Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-06","conditions":"Endocrine Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer","enrollment":285},{"nctId":"NCT07490938","phase":"NA","title":"Electroacupuncture vs. Auricular Acupressure vs. Waitlist Control for Breast Cancer Endocrine Therapy-Related Joint Pain","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2026-04","conditions":"Breast Cancer Survivors, Endocrine Therapy-Induced Joint Pain","enrollment":200},{"nctId":"NCT07346378","phase":"NA","title":"Clinical Study on the Safety and Efficacy of Temporal Interference Stimulation in the Treatment of Post-Stroke Aphasia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Anhui Medical University","startDate":"2025-12-01","conditions":"Post-stroke Aphasia","enrollment":40},{"nctId":"NCT04894643","phase":"NA","title":"Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer","status":"RECRUITING","sponsor":"EBG MedAustron GmbH","startDate":"2020-09-14","conditions":"Pancreatic Cancer, Proton Therapy","enrollment":10},{"nctId":"NCT07189598","phase":"NA","title":"Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer","status":"RECRUITING","sponsor":"Center Eugene Marquis","startDate":"2026-04-01","conditions":"High Risk Prostate Cancer","enrollment":390},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT05109728","phase":"PHASE1","title":"A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-05-10","conditions":"Glioblastoma","enrollment":65},{"nctId":"NCT07472868","phase":"PHASE3","title":"Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"J. W. A. Burger","startDate":"2026-03-03","conditions":"Locally Advanced Rectal Carcinoma","enrollment":394},{"nctId":"NCT07471659","phase":"NA","title":"Effect of Daily Humiome® Post LB Intake on Wellbeing in Older Individuals With Moderate Stress Levels","status":"NOT_YET_RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2026-03-01","conditions":"Stress","enrollment":200},{"nctId":"NCT07467746","phase":"PHASE2","title":"Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids","status":"NOT_YET_RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2026-04","conditions":"Amyotrophic Lateral Sclerosis","enrollment":84},{"nctId":"NCT07374224","phase":"PHASE1","title":"A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet","status":"RECRUITING","sponsor":"Guangzhou Lupeng Pharmaceutical Company LTD.","startDate":"2026-03-05","conditions":"Clinical Pharmacology","enrollment":28},{"nctId":"NCT07456917","phase":"NA","title":"Effects of BREA and MFT Expansion Appliances on Upper Airway Dimensions","status":"COMPLETED","sponsor":"Medical University of Silesia","startDate":"2020-02-01","conditions":"Maxillary Constriction in Growing Children, Transverse Maxillary Deficiency, Upper Airway Morphology in Children","enrollment":79},{"nctId":"NCT07283094","phase":"PHASE1","title":"FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-02-03","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndrome","enrollment":33},{"nctId":"NCT05681195","phase":"PHASE2","title":"Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas","status":"RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2024-04-25","conditions":"Primary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Relapsed Cancer","enrollment":15},{"nctId":"NCT06136728","phase":"PHASE4","title":"Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis","status":"RECRUITING","sponsor":"MGH Institute of Health Professions","startDate":"2024-06-12","conditions":"Multiple Sclerosis","enrollment":48},{"nctId":"NCT05721248","phase":"PHASE2","title":"STOP-HER2: Stopping Trastuzumab in HER2+ MBC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2023-04-19","conditions":"Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer","enrollment":82},{"nctId":"NCT06467708","phase":"NA","title":"Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-02-11","conditions":"TBI (Traumatic Brain Injury)","enrollment":42},{"nctId":"NCT03909412","phase":"PHASE1","title":"Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2019-10-08","conditions":"Multiple Myeloma","enrollment":18},{"nctId":"NCT06253520","phase":"PHASE1","title":"Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-05-16","conditions":"Metastatic Solid Cancers, Colorectal Cancer, Breast Cancer","enrollment":210},{"nctId":"NCT05789173","phase":"EARLY_PHASE1","title":"Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-10-06","conditions":"Drug-Drug Interaction","enrollment":60},{"nctId":"NCT06064812","phase":"PHASE1, PHASE2","title":"A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.","status":"RECRUITING","sponsor":"Forward Pharmaceuticals Co., Ltd.","startDate":"2023-09-12","conditions":"Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage IV","enrollment":99},{"nctId":"NCT04855422","phase":"","title":"Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2021-07-14","conditions":"Transplant; Complication, Rejection","enrollment":42},{"nctId":"NCT05635734","phase":"PHASE1, PHASE2","title":"Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cantex Pharmaceuticals","startDate":"2023-09-05","conditions":"Glioblastoma","enrollment":18},{"nctId":"NCT07389278","phase":"PHASE1, PHASE2","title":"Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)","status":"NOT_YET_RECRUITING","sponsor":"Sabine Mueller, MD, PhD","startDate":"2026-03-09","conditions":"Glioblastoma, High-Grade Glioma (WHO III-IV), High-grade Glioma","enrollment":97},{"nctId":"NCT07372040","phase":"PHASE2","title":"Add-on Diuretics in Acute Decompensated Heart Failure","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"Acute Decompensated Heart Failure","enrollment":66},{"nctId":"NCT05459571","phase":"PHASE2","title":"Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma","status":"COMPLETED","sponsor":"Kite, A Gilead Company","startDate":"2022-08-09","conditions":"Relapsed or Refractory Large B-cell Lymphoma","enrollment":35},{"nctId":"NCT07258771","phase":"PHASE4","title":"Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis","status":"RECRUITING","sponsor":"Berinstein, Jeffrey","startDate":"2026-01-16","conditions":"Ulcerative Colitis Acute","enrollment":110},{"nctId":"NCT06484491","phase":"NA","title":"IMPT Dose Escalation for NSCLC (HyDose)","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2025-09-01","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":87},{"nctId":"NCT04963803","phase":"NA","title":"Improving Aphasia Using Electrical Brain Stimulation","status":"COMPLETED","sponsor":"Syracuse University","startDate":"2021-07-12","conditions":"Stroke, Aphasia","enrollment":23},{"nctId":"NCT05442944","phase":"NA","title":"Dynamic and Static Balance and the Speed of Reaction in the Elderly","status":"COMPLETED","sponsor":"Anna Olczak","startDate":"2011-03-02","conditions":"Spondyloarthritis","enrollment":60},{"nctId":"NCT04733027","phase":"EARLY_PHASE1","title":"First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Curie","startDate":"2021-05-18","conditions":"Metastatic Solid Tumor Cancer","enrollment":57},{"nctId":"NCT03972488","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Advanced Accelerator Applications","startDate":"2020-01-08","conditions":"Gastro-enteropancreatic Neuroendocrine Tumor","enrollment":226},{"nctId":"NCT07349368","phase":"NA","title":"Effectiveness and Cost-effectiveness of Simultaneous Screening and Intervention for Antenatal Depression and Anxiety Symptoms From a Transdiagnostic Perspective: A Scale-up Feasibility Study","status":"COMPLETED","sponsor":"Anhui Medical University","startDate":"2021-03-24","conditions":"Antenatal Depression, Antenatal Anxiety","enrollment":3314},{"nctId":"NCT06305182","phase":"PHASE2","title":"Metreleptin in Anorexia Nervosa","status":"RECRUITING","sponsor":"Gabriella Milos","startDate":"2024-05-31","conditions":"Anorexia Nervosa","enrollment":50},{"nctId":"NCT05577741","phase":"NA","title":"Effect of the Enriched Environment on the Risk of Relapse","status":"COMPLETED","sponsor":"Centre Hospitalier Henri Laborit","startDate":"2022-11-29","conditions":"Alcoholic Relapse","enrollment":135},{"nctId":"NCT02577029","phase":"PHASE2","title":"Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-12","conditions":"Hepatitis B, Hepatitis D","enrollment":79},{"nctId":"NCT06456268","phase":"NA","title":"VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)","status":"RECRUITING","sponsor":"Columbia University","startDate":"2026-06","conditions":"ACL, Opioid Use, Cryotherapy Effect","enrollment":130},{"nctId":"NCT06479070","phase":"NA","title":"Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.","status":"RECRUITING","sponsor":"Institut de Cancérologie de Lorraine","startDate":"2024-09-30","conditions":"SCC - Squamous Cell Carcinoma, Upper Aero-digestive Tract (UADT) Neoplasm","enrollment":188},{"nctId":"NCT03423628","phase":"PHASE1","title":"A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2018-04-02","conditions":"Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme, Brain Neoplasms, Malignant","enrollment":180},{"nctId":"NCT06514898","phase":"PHASE1","title":"Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2025-05-05","conditions":"Recurrent Group 3 Medulloblastoma, Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma","enrollment":12},{"nctId":"NCT04612751","phase":"PHASE1","title":"Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-02-02","conditions":"Advanced or Metastatic NSCLC","enrollment":155},{"nctId":"NCT03013998","phase":"PHASE1, PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":"Previously Untreated Relapsed Refractory Acute Myeloid Leukemia","enrollment":3000},{"nctId":"NCT07282145","phase":"PHASE1","title":"Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers","status":"RECRUITING","sponsor":"Bichedam Co., Ltd.","startDate":"2025-09-11","conditions":"Essential Hypertension","enrollment":56},{"nctId":"NCT07281443","phase":"NA","title":"MDA and Targeted Control Against Plasmodium Carriage in the Sahel","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut de Recherche pour le Developpement","startDate":"2024-09-23","conditions":"Malaria, Falciparum, Malaria, Asymptomatic Parasitaemia","enrollment":18000},{"nctId":"NCT07271173","phase":"NA","title":"Study on the Effects of Unilateral Resistance Training on Lower Limb Muscle Strength and Symmetry After Anterior Cruciate Ligament Reconstruction Surgery","status":"COMPLETED","sponsor":"Peking University Third Hospital","startDate":"2025-04-06","conditions":"Anterior Cruciate Ligament Reconstruction Rehabilitation","enrollment":48},{"nctId":"NCT07270302","phase":"PHASE1, PHASE2","title":"Nebulized Nasal Steroids","status":"NOT_YET_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-12","conditions":"Chronic Rhinosinusitis","enrollment":50},{"nctId":"NCT05763563","phase":"NA","title":"Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2023-02-21","conditions":"Lymphoma, Leukemia, Myeloma","enrollment":20},{"nctId":"NCT05623397","phase":"","title":"A Deep Learning Method to Evaluate QT on Ribociclib","status":"COMPLETED","sponsor":"CMC Ambroise Paré","startDate":"2023-07-28","conditions":"Breast Cancer, Ribociclib","enrollment":70},{"nctId":"NCT06143397","phase":"NA","title":"Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.","status":"COMPLETED","sponsor":"Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization","startDate":"2023-11-20","conditions":"Multiple Sclerosis, Overactive Bladder Syndrome","enrollment":42},{"nctId":"NCT07058428","phase":"PHASE3","title":"FSRT Combines With Bevacizumab for Multiple Brain Metastases in Lung Adenocarcinoma","status":"RECRUITING","sponsor":"Sun Yat-Sen University Cancer Center","startDate":"2025-06-30","conditions":"Multiple Brain Metastases in Lung Adenocarcinoma","enrollment":258},{"nctId":"NCT06812611","phase":"NA","title":"Effects of High Intensity Laser Therapy in Muscle Injuries","status":"NOT_YET_RECRUITING","sponsor":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","startDate":"2025-12-01","conditions":"Muscle Tear","enrollment":24},{"nctId":"NCT03777813","phase":"PHASE2","title":"Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2018-12-05","conditions":"Esophagus Cancer, Unresectable Malignant Neoplasm","enrollment":112},{"nctId":"NCT06547021","phase":"NA","title":"Investigating Different Frequencies of Transcranial Electrical Stimulations in Dementia Population","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2024-09-20","conditions":"Dementia","enrollment":100},{"nctId":"NCT06841705","phase":"PHASE2","title":"Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial","status":"RECRUITING","sponsor":"Shilpa Grover, MD, MPH","startDate":"2025-07-15","conditions":"Immune Checkpoint Inhibitor-Related Colitis","enrollment":80},{"nctId":"NCT07209891","phase":"NA","title":"COMPARISON STUY OF KINESIOTAPE AND LOW-LEVEL LASER THERAPY ON HYPERTROPHIC SCAR","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-10-05","conditions":"Hypertrophic Scar, Burn Scar (Post-burn), Burns","enrollment":60},{"nctId":"NCT07209709","phase":"NA","title":"Should Dual Task Training or Action Observation Therapy be Used in Geriatric Individuals?","status":"NOT_YET_RECRUITING","sponsor":"Inonu University","startDate":"2025-12-30","conditions":"Comparison of the Effects of Different Therapies in Geriatric Individuals","enrollment":66},{"nctId":"NCT05428488","phase":"PHASE3","title":"Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2022-11-28","conditions":"Rheumatoid Arthritis","enrollment":220},{"nctId":"NCT06086704","phase":"PHASE2","title":"Study of 18F-FFNP Breast PET/MRI","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-09-25","conditions":"Breast Cancer","enrollment":53},{"nctId":"NCT07201155","phase":"","title":"The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-05-01","conditions":"Hyperglycemia in Critically Ill Patients","enrollment":55},{"nctId":"NCT02701088","phase":"PHASE2","title":"Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Francois Baclesse","startDate":"2015-12","conditions":"Locally Advanced Anal Canal Cancer","enrollment":71},{"nctId":"NCT06443502","phase":"PHASE3","title":"A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis","status":"RECRUITING","sponsor":"Takeda","startDate":"2024-11-19","conditions":"Pouchitis","enrollment":30},{"nctId":"NCT07173738","phase":"PHASE1","title":"Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2018-06-11","conditions":"Pulmonary Arterial Hypertension","enrollment":44},{"nctId":"NCT02598349","phase":"PHASE2","title":"Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas","status":"RECRUITING","sponsor":"Proton Collaborative Group","startDate":"2016-04","conditions":"Pancreatic Cancer","enrollment":60},{"nctId":"NCT06355180","phase":"NA","title":"Esketamine vs ECT for Acute Suicidality","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2024-04-16","conditions":"Mood Disorders, Suicidal Ideation, Depressive Episode","enrollment":340},{"nctId":"NCT02470897","phase":"NA","title":"Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2015-07-24","conditions":"Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma","enrollment":115},{"nctId":"NCT06207981","phase":"PHASE3","title":"Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA","status":"RECRUITING","sponsor":"Federation Francophone de Cancerologie Digestive","startDate":"2024-02-26","conditions":"Anal Cancer","enrollment":310},{"nctId":"NCT04332848","phase":"PHASE4","title":"Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-07-28","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT05607823","phase":"NA","title":"Adding Core Stabilization Training to Manuel Therapy in Temporomandibular Joint Disorders","status":"COMPLETED","sponsor":"Marmara University","startDate":"2022-11-06","conditions":"Temporomandibular Joint Disorders","enrollment":45},{"nctId":"NCT07129499","phase":"NA","title":"Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Famous Medical Technology Co., Ltd.","startDate":"2025-08-15","conditions":"Colorectal Adenoma, High Risk, TCM","enrollment":450},{"nctId":"NCT06859866","phase":"NA","title":"Efficacy of Adjunctive At-Home Photodynamic Therapy (aPDT) in the Treatment of Peri-Implant Mucositis","status":"RECRUITING","sponsor":"Koite Health Oy","startDate":"2025-04-29","conditions":"Peri-implant Mucositis","enrollment":30},{"nctId":"NCT05284643","phase":"NA","title":"Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma","status":"RECRUITING","sponsor":"University of Miami","startDate":"2022-09-30","conditions":"Recurrent Glioblastoma","enrollment":96},{"nctId":"NCT06172127","phase":"PHASE2","title":"PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer","status":"RECRUITING","sponsor":"MedSIR","startDate":"2024-07-22","conditions":"HER2-positive Breast Cancer","enrollment":165},{"nctId":"NCT07064902","phase":"PHASE2","title":"Ivonescimab Combined With Chemoradiotherapy in High-Risk Locoregionally Advanced Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-08-01","conditions":"Nasopharyngeal Carcinoma (NPC)","enrollment":48},{"nctId":"NCT07061444","phase":"NA","title":"Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients","status":"RECRUITING","sponsor":"Ceren Derya Gültekin","startDate":"2025-08-02","conditions":"Hematopoietic Stem Cell Transplantation (HSCT), Pulmonary Rehabilitation, Inspiratory Muscle Training","enrollment":45},{"nctId":"NCT06379087","phase":"PHASE2","title":"Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC","status":"RECRUITING","sponsor":"Ji Yongling","startDate":"2024-05-01","conditions":"Non-Small Cell Lung Cancer","enrollment":20},{"nctId":"NCT07037680","phase":"PHASE2","title":"Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT","status":"RECRUITING","sponsor":"JIANYANG WANG","startDate":"2024-01-01","conditions":"Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy, Safety","enrollment":44},{"nctId":"NCT06951048","phase":"NA","title":"The Role of Lower Limb Neural Mobilization in Improving Balance and Performance","status":"COMPLETED","sponsor":"Uludag University","startDate":"2025-03-01","conditions":"Healty Volunteers, Sedantary, Young","enrollment":60},{"nctId":"NCT03359291","phase":"PHASE1","title":"Clinical Study to Investigate the Effect of Macitentan on the Concentrations of Rosuvastatin in the Blood of Healthy Male Subjects","status":"COMPLETED","sponsor":"Actelion","startDate":"2017-11-03","conditions":"Healthy Subjects","enrollment":20},{"nctId":"NCT00392327","phase":"PHASE3","title":"Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2007-05-23","conditions":"Anaplastic Medulloblastoma, Medulloblastoma","enrollment":379},{"nctId":"NCT01804790","phase":"PHASE3","title":"Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer","status":"COMPLETED","sponsor":"UNICANCER","startDate":"2012-01","conditions":"Cancer of the Rectum","enrollment":461},{"nctId":"NCT03612791","phase":"PHASE2","title":"Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2018-08-13","conditions":"Locally Advanced Cervical Cancer","enrollment":189},{"nctId":"NCT03101995","phase":"PHASE2","title":"Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease","status":"RECRUITING","sponsor":"National Institute of Cancerología","startDate":"2018-01-16","conditions":"Cervical Cancer","enrollment":18},{"nctId":"NCT06971549","phase":"NA","title":"Accelerated iTBS for Depression: Monitoring Brain Hemodynamics With Simultaneous iTBS/fNIRS","status":"RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2025-03-19","conditions":"Depression","enrollment":1},{"nctId":"NCT06719063","phase":"NA","title":"Effect of Immersive Virtual Reality With Multisensory Stimulation on the Functional Impact of Hemineglect Secondary to a Right-Sided Stroke","status":"RECRUITING","sponsor":"Hopital La Musse","startDate":"2025-04-04","conditions":"Stroke, Hemineglect, Neuropsychology","enrollment":3},{"nctId":"NCT02999087","phase":"PHASE3","title":"Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Oncologie Radiotherapie Tete et Cou","startDate":"2017-09-14","conditions":"HNSCC","enrollment":707},{"nctId":"NCT02417064","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-10","conditions":"Treatment-resistant Depression","enrollment":346},{"nctId":"NCT03434041","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-25","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":252},{"nctId":"NCT02418585","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-07","conditions":"Treatment-resistant Depression","enrollment":236},{"nctId":"NCT02422186","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-20","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":139},{"nctId":"NCT06468189","phase":"NA","title":"Clinical and Neurophysiological Effects of tDCS to Visual and Motor Cortex in Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Istanbul Medipol University Hospital","startDate":"2024-03-01","conditions":"Migraine","enrollment":80},{"nctId":"NCT06735807","phase":"NA","title":"Generated AI-informed Intervention (Emohaa) vs Group ACT vs WL on Emotional Distress","status":"COMPLETED","sponsor":"Central University of Finance and Economics, China","startDate":"2024-09-20","conditions":"Artificial Intelligence (AI), Depression - Major Depressive Disorder, Anxiety","enrollment":80},{"nctId":"NCT04517656","phase":"NA","title":"Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2022-05-25","conditions":"Malignant Hemopathy","enrollment":40},{"nctId":"NCT04251065","phase":"PHASE2","title":"Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH","status":"TERMINATED","sponsor":"Fondazione Italiana Linfomi - ETS","startDate":"2020-09-03","conditions":"Refractory T-Cell Lymphoma, Relapsed T-Cell Lymphoma","enrollment":8},{"nctId":"NCT05575882","phase":"NA","title":"Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.","status":"RECRUITING","sponsor":"NAOS Argentina S.A.","startDate":"2022-11-03","conditions":"Atopic Dermatitis, Eczema, Atopic","enrollment":100},{"nctId":"NCT05734183","phase":"NA","title":"Multisensorial IMmersive Experiences (MIME) in Disorders of Consciousness","status":"COMPLETED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-10-29","conditions":"Disorder of Consciousness, Acquired Brain Injury","enrollment":20},{"nctId":"NCT06880289","phase":"PHASE2","title":"Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regina Elena Cancer Institute","startDate":"2020-09-16","conditions":"Squamous Cell Tumors of the Head and Neck","enrollment":91},{"nctId":"NCT06246344","phase":"","title":"Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2023-12-01","conditions":"Rectal Cancer","enrollment":128},{"nctId":"NCT06869239","phase":"","title":"Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy","status":"RECRUITING","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2025-02-25","conditions":"Limited-stage Small Cell Lung Cancer (LS-SCLC)","enrollment":65},{"nctId":"NCT06855316","phase":"NA","title":"Evaluating Combined Electromagnetic Stimulation for Enhanced Physical and Psychological Recovery in Athletes with DOMS","status":"NOT_YET_RECRUITING","sponsor":"Sierra Varona SL","startDate":"2025-02-24","conditions":"Recovery, Psychological, Transcranial Magnetic Stimulation","enrollment":48},{"nctId":"NCT06851286","phase":"NA","title":"Effects of Laughter Therapy on Postpartum Mothers' Stress, Sleep, and Breastfeeding","status":"ENROLLING_BY_INVITATION","sponsor":"Selcuk University","startDate":"2025-02-10","conditions":"Postnatal Care, Lactation","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Concomitant therapy 10 days","genericName":"Concomitant therapy 10 days","companyName":"Incheon St.Mary's Hospital","companyId":"incheon-st-mary-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug is used to treat various infections by inhibiting the bacterial cell wall synthesis. Used for Community-acquired pneumonia, Skin and soft tissue infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}